140 related articles for article (PubMed ID: 31452789)
1. Deregulation of folate pathway gene expression correlates with poor prognosis in acute leukemia.
Organista-Nava J; Gómez-Gómez Y; Del Moral-Hernandez O; Illades-Aguiar B; Gómez-Santamaria J; Rivera-Ramírez AB; Saavedra-Herrera MV; Jimenez-López MA; Leyva-Vázquez MA
Oncol Lett; 2019 Sep; 18(3):3115-3127. PubMed ID: 31452789
[TBL] [Abstract][Full Text] [Related]
2. Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue.
Stamp LK; Hazlett J; Highton J; Hessian PA
J Rheumatol; 2013 Sep; 40(9):1519-22. PubMed ID: 23858048
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population.
Hashiguchi M; Shimizu M; Hakamata J; Tsuru T; Tanaka T; Suzaki M; Miyawaki K; Chiyoda T; Takeuchi O; Hiratsuka J; Irie S; Maruyama J; Mochizuki M
J Pharm Health Care Sci; 2016; 2():35. PubMed ID: 27980801
[TBL] [Abstract][Full Text] [Related]
4. mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method.
Rots MG; Willey JC; Jansen G; Van Zantwijk CH; Noordhuis P; DeMuth JP; Kuiper E; Veerman AJ; Pieters R; Peters GJ
Leukemia; 2000 Dec; 14(12):2166-75. PubMed ID: 11187907
[TBL] [Abstract][Full Text] [Related]
5. Do SNPs in folate pharmacokinetic pathway alter levels of intracellular methotrexate polyglutamates and affect response? A prospective study in Indian patients.
Sandhu A; Ahmad S; Kaur J; Bhatnagar A; Dhawan V; Dhir V
Clin Rheumatol; 2018 Dec; 37(12):3221-3228. PubMed ID: 30022368
[TBL] [Abstract][Full Text] [Related]
6. The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis.
Song Z; Hu Y; Liu S; Jiang D; Yi Z; Benjamin MM; Zhao R
Front Pharmacol; 2021; 12():757464. PubMed ID: 34744734
[No Abstract] [Full Text] [Related]
7. Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy.
Leclerc GJ; Mou C; Leclerc GM; Mian AM; Barredo JC
Leukemia; 2010 Mar; 24(3):552-62. PubMed ID: 20072153
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia.
Zgheib NK; Akra-Ismail M; Aridi C; Mahfouz R; Abboud MR; Solh H; Muwakkit SA
Pharmacogenet Genomics; 2014 Aug; 24(8):387-96. PubMed ID: 25007187
[TBL] [Abstract][Full Text] [Related]
9. Variable expression of RFC1 in human leukemia cell lines resistant to antifolates.
Kobayashi H; Takemura Y; Ohnuma T
Cancer Lett; 1998 Feb; 124(2):135-42. PubMed ID: 9500202
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients.
Moya P; Salazar J; Arranz MJ; Díaz-Torné C; del Río E; Casademont J; Corominas H; Baiget M
Pharmacogenomics; 2016; 17(1):25-9. PubMed ID: 26652611
[TBL] [Abstract][Full Text] [Related]
11. Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients.
Odin E; Wettergren Y; Nilsson S; Willén R; Carlsson G; Spears CP; Larsson L; Gustavsson B
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6012-9. PubMed ID: 14676127
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate.
Cwiklinska M; Czogala M; Kwiecinska K; Madetko-Talowska A; Szafarz M; Pawinska K; Wieczorek A; Klekawka T; Rej M; Stepien K; Halubiec P; Lazarczyk A; Miklusiak K; Bik-Multanowski M; Balwierz W; Skoczen S
Front Pediatr; 2020; 8():307. PubMed ID: 32612964
[No Abstract] [Full Text] [Related]
13. Reduced folate carrier 1 gene expression levels are correlated with methotrexate efficacy in Japanese patients with rheumatoid arthritis.
Tazoe Y; Hayashi H; Tsuboi S; Shioura T; Matsuyama T; Yamada H; Hirai K; Tsuji D; Inoue K; Sugiyama T; Itoh K
Drug Metab Pharmacokinet; 2015 Jun; 30(3):227-30. PubMed ID: 26003891
[TBL] [Abstract][Full Text] [Related]
14. Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients.
van der Straaten RJ; Wessels JA; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Allaart CF; Bogaartz J; Tiller M; Huizinga TW; Guchelaar HJ
Pharmacogenomics; 2007 Feb; 8(2):141-50. PubMed ID: 17286537
[TBL] [Abstract][Full Text] [Related]
15. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults.
Gemmati D; Ongaro A; Scapoli GL; Della Porta M; Tognazzo S; Serino ML; Di Bona E; Rodeghiero F; Gilli G; Reverberi R; Caruso A; Pasello M; Pellati A; De Mattei M
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):787-94. PubMed ID: 15159311
[TBL] [Abstract][Full Text] [Related]
16. Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.
Moscow JA; Connolly T; Myers TG; Cheng CC; Paull K; Cowan KH
Int J Cancer; 1997 Jul; 72(1):184-90. PubMed ID: 9212241
[TBL] [Abstract][Full Text] [Related]
17. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
[TBL] [Abstract][Full Text] [Related]
18. High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.
Maezawa Y; Sakamaki K; Oue N; Kimura Y; Hashimoto I; Hara K; Kano K; Aoyama T; Hiroshima Y; Yamada T; Yamamoto N; Ogata T; Ito H; Cho H; Shiozawa M; Yoshikawa T; Morinaga S; Rino Y; Yasui W; Masuda M; Miyagi Y; Oshima T
J Cancer Res Clin Oncol; 2020 Jan; 146(1):75-86. PubMed ID: 31754833
[TBL] [Abstract][Full Text] [Related]
19. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients.
Takatori R; Takahashi KA; Tokunaga D; Hojo T; Fujioka M; Asano T; Hirata T; Kawahito Y; Satomi Y; Nishino H; Tanaka T; Hirota Y; Kubo T
Clin Exp Rheumatol; 2006; 24(5):546-54. PubMed ID: 17181924
[TBL] [Abstract][Full Text] [Related]
20. Effects of overexpression of gamma-Glutamyl hydrolase on methotrexate metabolism and resistance.
Cole PD; Kamen BA; Gorlick R; Banerjee D; Smith AK; Magill E; Bertino JR
Cancer Res; 2001 Jun; 61(11):4599-604. PubMed ID: 11389096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
